3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Interventions
Radiotherapy
11
Brachytherapy
8
fludarabine
5
Radiation
5
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
5
Cyclophosphamide
5
aldesleukin
4
Surveys and Questionnaires
4
Magnetic Resonance Spectroscopy
4
Cisplatin
4
fludarabine phosphate
3
durvalumab
3
Vaccines, Synthetic
3
Radiosurgery
3
Papillomavirus Vaccines
3
Paclitaxel
3
Methods
3
Early Intervention, Educational
3
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
3
tremelimumab
2
entinostat
2
aflibercept
2
Vaccines
2
Trastuzumab
2
Topotecan
2
Therapeutics
2
Surgical Procedures, Operative
2
Psychiatric Rehabilitation
2
Platinum
2
Palliative Care
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vaginal Neoplasms
×
trastuzumab deruxtecan
×
Gynecologic
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled